IL1B and psoriasis: Regarding psoriasis, a study in which IL-1 inhibition was used in plaque psoriasis showed a decrease in PASI of only 13%, which was lower than that obtained with other biologic agents (anti-TNF, anti-IL-17, and anti-IL-12/-23p40) [102].